Filgrastim--a hematopoietic growth factor (r-metHuC-CSF) for treatment of neutropenia caused by cytostatics
Ersbøll, J.
Ugeskrift for Laeger 153(38): 2647-2650
1991
ISSN/ISBN: 0041-5782 PMID: 1719682 Document Number: 387414
Document emailed within 1 workday
Related Documents
Marcos Sánchez, F.; Juárez Ucelay, F.; Plaza Díaz, R.; Durán Pérez-Navarro, A. 1995: Filgrastim in the treatment of severe neutropenia in a patient with bilobar pneumonia Anales de Medicina Interna 12(2): 100-101Motoyoshi, K. 1990: Advances in hematopoietic growth factor research and bone marrow transplantation--hematopoietic stem cells and their growth factors Nihon Rinsho. Japanese Journal of Clinical Medicine 48(9): 1941-1948
Manfredi, R.; Sabbatani, S. 2007: Multiple, repeated filgrastim treatment cycles to recover severe, recurring pegylated interferon-related neutropenia Hepato-Gastroenterology 54(78): 4PagePreceedingTableContent
Nemunaitis, J. 1993: The role of hematopoietic growth factor in the treatment of graft failure Bone Marrow Transplantation 12(Suppl 3): S50-S52
Andresen, J.L.; Ehlers, N. 1998: Chemotaxis of human keratocytes is increased by platelet-derived growth factor-BB, epidermal growth factor, transforming growth factor-alpha, acidic fibroblast growth factor, insulin-like growth factor-I, and transforming growth factor-beta Current Eye Research 17(1): 79-87
Rizzino, A.; Kazakoff, P.; Ruff, E.; Kuszynski, C.; Nebelsick, J. 1988: Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor Cancer Research 48(15): 4266-4271
Strife, A.; Lambek, C.; Perez, A.; Darzynkiewicz, Z.; Skierski, J.; Gulati, S.; Haley, J.D.; ten Dijke, P.; Iwata, K.K.; Clarkson, B.D. 1991: The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood Cancer Research 51(18): 4828-4836
Broudy, V.C.; Harlan, J.M.; Adamson, J.W. 1987: Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells Journal of Immunology 138(12): 4298-4302
Pérez-Calvo, J.; Fernández-Hidalgo, O.; Subirá, M.L.; Martín-Algarra, S.; Salgado, E.; Brugarolas, A. 2001: Mobilization of hematopoietic progenitor cells with a combination of docetaxel, adriamycin, 5-fluorouracil and filgrastim in breast cancer patients Haematologica 86(1): 100-101
Biesma, B.; Willemse, P.H.; Vellenga, E.; Limburg, P.C.; Aalders, J.G.; de Vries, E.G. 1991: The hematopoietic growth factor GM-CSF in chemotherapy for ovarian carcinoma Nederlands Tijdschrift Voor Geneeskunde 135(10): 420-424
Oster, W.; Lindemann, A.; Ganser, A.; Mertelsmann, R.; Herrmann, F. 1988: Constitutive expression of hematopoietic growth factor genes by acute myeloblastic leukemia cells Behring Institute Mitteilungen 83: 68-79
Miller, A.M.; Sandler, E.; Kobb, S.M.; Eastgate, J.; Zucali, J. 1993: Hematopoietic growth factor induction of gamma-glutamyl transferase in the KG-1 myeloid cell line Experimental Hematology 21(1): 9-15
Velleman, S.G.; McFarland, D.C. 1999: Influence of fibroblast growth factor, insulin-like growth factor I, and transforming growth factor beta on satellite cell type i collagen expression and localization during differentiation Cytobios 100(394): 101-110
Peschen, M.; Grenz, H.; Grothe, C.; Schöpf, E.; Vanscheidt, W. 1998: Patterns of epidermal growth factor receptor, basic fibroblast growth factor and transforming growth factor-beta3 expression in skin with chronic venous insufficiency European Journal of Dermatology: Ejd 8(5): 334-338
Korsak, J. 2008: Clinical application of granulocyte concentrates in neutropenia caused by immunosupressive treatment Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(142): 346-350
Abdullah, N.A.; Torres, B.A.; Basu, M.; Johnson, H.M. 1989: Differential effects of epidermal growth factor, transforming growth factor-alpha, and vaccinia virus growth factor in the positive regulation of IFN-gamma production Journal of Immunology 143(1): 113-117
Ionescu, C.; Berindan-Neagoe, I.; Burz, C.; Balacescu, O.; Balacescu, L.; Tudoran, O.; Asztalos, R.; Irimie, A. 2011: The clinical implications of platelet derived growth factor B, vascular endothelial growth factor and basic fibroblast growth factor in colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 16(2): 274-276
Kara, I.Oguz.; Sahin, B.; Gunesacar, R.; Unsal, C. 2006: Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma Advances in Therapy 23(4): 635-645
Bagby, G.C.; Segal, G.M.; Auerbach, A.D.; Onega, T.; Keeble, W.; Heinrich, M.C. 1993: Constitutive and induced expression of hematopoietic growth factor genes by fibroblasts from children with Fanconi anemia Experimental Hematology 21(11): 1419-1426
Barak, Y.; Hahn, T.; Pecht, M.; Karov, Y.; Berrebi, A.; Zaizov, R.; Stark, B.; Buchner, V.; Burstein, Y.; Trainin, N. 1992: Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth Experimental Hematology 20(2): 173-177